Advertisement

Autoimmune diseases of the liver

  • R. N. M. MacSween
  • P. A. Berg

Abstract

Chronic active hepatitis presents an extremely variable clinical picture of poorly defined aetiology, with a spectrum of disease pattern in which acute and chronic inflammatory processes co-exist. In the early stages it may resemble an episode of acute viral hepatitis; it pursues a pattern of relapse and remission, the duration of each phase being unpredictable. In some instances the disease may revert to an inactive form, in others there may be a rapid progression to hepatic cirrhosis, while in further instances the cirrhosis evolves more slowly. In these latter stages the disease pattern is that of an established cirrhosis. Many patients may not present until this late stage, having been previously symptom free and with no history of any earlier acute episode.

Keywords

Chronic Liver Disease Primary Biliary Cirrhosis Chronic Active Hepatitis Portal Tract Acute Viral Hepatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Waldenstroem, J. (1950). Leberblutproteine und Nahrungsgenesis— Stoffwechsel. Report of session: Bad Kissingen, special volume 15, p. 8Google Scholar
  2. 2.
    Bearn, A. G., Kunkel, H. G. and Slater, R. J. (1956). The problem of chronic liver disease in young women. Am. J. Med., 21, 3PubMedCrossRefGoogle Scholar
  3. 3.
    Saint, E. G., King, W. E., Joske, R. A. and Finckh, E. S. (1953). The course of infectious hepatitis with special reference to prognosis and the chronic stage. Aust. Ann. Med., 2, 113PubMedGoogle Scholar
  4. 4.
    Joske, R. A. and King, W. E. (1955). The ‘L. E. cell’ phenomenon in active chronic viral hepatitis. Lancet, ii, 477CrossRefGoogle Scholar
  5. 5.
    Mackay, I. R., Taft, L. I. and Cowling, D. C. (1956). Lupoid hepatitis. Lancet, ii, 1323CrossRefGoogle Scholar
  6. 6.
    Mackay, I. R. and Wood, I. J. (1962). Lupoid hepatitis: a comparison of 22 cases with other types of chronic liver disease. Quart. J. Med., 31, 485Google Scholar
  7. 7.
    Mackay, I. R. and Whittingham, S. (1967). Autoimmune chronic hepatitis. Postgraduate Med., 41, 72Google Scholar
  8. 8.
    Mistilis, S. P. and Blackburn, C. R. B. (1970). Active chronic hepatitis. Am. J. Med., 48, 484PubMedCrossRefGoogle Scholar
  9. 9.
    Sherlock, S. (1970). The immunology of liver disease. Am. J. Med., 49, 693PubMedCrossRefGoogle Scholar
  10. 10.
    de Groote, J., Desmet, V. J., Gedigk, P., Korb, G., Popper, H., Poulsen, H., Scheuer, P., Schmid, M., Thaler, H., Uehlinger, E. and Wepler, W. (1968). A classification of chronic hepatitis. Lancet, ii, 626CrossRefGoogle Scholar
  11. 11.
    Schmid, M. (1971). Einteilung und Klinik der chronischen Hepatitis. Leber, Magen, Darm, 1, 56Google Scholar
  12. 12.
    Thaler, H. (1973). Systematische, morphologische und klinische Probleme der chronischen Hepatitis. Internist Berlin, 14, 604PubMedGoogle Scholar
  13. 13.
    Popper, H. and Schaffner, F. (1971). The vocabulary of chronic hepatitis. New Engl. J. Med., 284, 1154PubMedCrossRefGoogle Scholar
  14. 14.
    Scheuer, P. J. (1973). In Liver Biopsy Interpretation, 2nd ed., p. 33 (London: Bailliere Tindall)Google Scholar
  15. 15.
    Baggenstoss, A. H., Summerskill, W. H. J. and Ammon, H. V. (1974). The morphology of chronic hepatitis. In The Liver and its Diseases. F. Schaffner, S. Sherlock and C. M. Leevy (eds.) p. 199 (New York: Intercontinental Medical Book Corporation)Google Scholar
  16. 16.
    Tisdale, W. A. (1963). Subacute hepatitis. New Engl. J. Med., 268, 85PubMedCrossRefGoogle Scholar
  17. 17.
    Boyer, J. L. and Klatskin, G. (1970). Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). New Engl. J. Med., 283, 1063PubMedCrossRefGoogle Scholar
  18. 18.
    Selmair, H., Vido, I., Wildhirt, E. and Ostmans, H. (1970). Die chronisch nekrotisierende Hepatitis. Dtsch. Med. Wschr. 95, 1397PubMedCrossRefGoogle Scholar
  19. 19.
    Schmid, M. (1966). Die chronische Hepatitis: Vergleichende klinische und biologische Untersuchungen. (Berlin-Heidelberg-New York: Springer)Google Scholar
  20. 20.
    Wepler, W. (1974). Die sogenannte chronische nekrotisierende Hepatitis. In Chronische HepatitisZirrhosen, p. 14 (Stuttgart: Georg Thieme Verlag)Google Scholar
  21. 21.
    Wildhirt, E. (1974). Die chronische-nekrotisierende Hepatitis. In Chronische HepatitisZirrhosen, p. 70 (Stuttgart: Georg Thieme Verlag)Google Scholar
  22. 22.
    Hadziyannis, S. J., Vissoulis, C., Moussouros, A. and Afroudakis, A. (1972). Cytoplasmic localisation of Australian antigen in the liver. Lancet, i, 976.CrossRefGoogle Scholar
  23. 23.
    Shikata, T., Uzawa, T., Yoshiwara, N., Akatsuka, T. and Yamazaki, S. (1974). Staining methods of Australia antigen in paraffin section— detection of cytoplasmic inclusion bodies. Jap. J. Exp. Med., 44, 25PubMedGoogle Scholar
  24. 24.
    Doniach, D., Roitt, I. M., Walker, J. G. and Sherlock, S. (1969). Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin. Exp. Immunol., 1, 237Google Scholar
  25. 25.
    Berg, P. A., Binder, T., Linduer, H., Bannaski, H., Maas, D., Henning, H. and Brügel, H. (1975). Heterogenitä t mitochondrialer Autoantikörper. Zur serologischen Diagnose der primä r-biliä ren Zirrhose und des Pseudo-Lupus erythematodes mit Hilfe von zwei verschiedenen Anti-genfraktionen. Dtsch. Med. Wschr., 100, 1123PubMedCrossRefGoogle Scholar
  26. 26.
    Berg, P. A., Traunecker, U. and Märker, A. (1973). Mitochondrial antibodies in non-hepatic diseases. Germ. Med. Monthly, 3, 58Google Scholar
  27. 27.
    Maas, D. and Schubothe, H. (1973). Ein Lupus-erythematodes-ä hnliches Syndrom mit antimitochondrialen Antikörpern. Dtsch. Med. Wschr., 98, 131PubMedCrossRefGoogle Scholar
  28. 28.
    Grob, P. J,, Müller-Schoop, J. W., Häcki, M. A. and Joller-Jemelka, H. (1975). Drug induced pseudolupus. Lancet, ii, 144CrossRefGoogle Scholar
  29. 29.
    Maas, D., Schubothe, H., Seenekamp, J., Genth, E., Maerker-Alzer, G., Droese, M., Hartl, P. W. and Schumacher, K. (1975). Zur Frage einer Induzierbarkeit des Pseudo-LE-Syndroms durch Arzneimittel. Vorlä ufige Ergenbnisse von Erhebungen bei 58 Fä llen. Dtsch. Med. Wschr., 100, 1555PubMedCrossRefGoogle Scholar
  30. 30.
    Rizzetto, M., Swana, G. and Doniach, D. (1973). Microsomal antibodies in active chronic hepatitis and other disorders. Clin. Exp. Immunol., 15, 331PubMedGoogle Scholar
  31. 31.
    Maclachlan, M. J., Rodnan, G. P., Cooper, W. M. and Fennell, R. H. (1965). Chronic active (lupoid) hepatitis. A clinical, serological and pathological study of 20 patients. Ann. Intern. Med., 62, 425PubMedGoogle Scholar
  32. 32.
    Mackay, I. R. (1972). Chronic hepatitis. Canad. Med. Ass. J., 106, 519PubMedGoogle Scholar
  33. 33.
    Schumacher, K. (1975). Immunpathologie der chronischen Hepatitis. Gastroenterologie und Stoffwechsel. (Stuttgart: Georg Thieme Verlag)Google Scholar
  34. 34.
    Berg, P. A. and Brandt, H. (1974). Die chronische-aggressive (lupoide) Hepatitis: Diagnose, Differentialdiagnose und Therapie. Therapiewoche, 24, 6, 521Google Scholar
  35. 35.
    Beck, J. S. (1961). Variations in the morphological patterns of ‘autoimmune’ nuclear fluorescence. Lancet, i, 1203CrossRefGoogle Scholar
  36. 36.
    Davis, P. and Read, A. E. (1975). Antibodies to double-stranded (native) DNA in active chronic hepatitis. Gut, 16, 413PubMedCrossRefGoogle Scholar
  37. 37.
    Berg, P. A. (1974). Immune response in acute viral hepatitis. Clin. Gastroenterol., 3, 255PubMedGoogle Scholar
  38. 38.
    Golding, P. L., Smith, M. and Williams, R. (1973). Multisystem involvement in chronic liver disease. Studies on the incidence and pathogenesis. Am. J. Med., 55, 772PubMedCrossRefGoogle Scholar
  39. 39.
    Grob, P. J., Jemelka, H. J. and Müller, J. W. (1971). B1A and SH antigen in chronic hepatitis. Gastroenterology, 61, 91PubMedGoogle Scholar
  40. 40.
    Kourilsky, O., Leroy, C. and Peltier, A. P. (1973). Complement and liver cell function in 53 patients with liver disease. Amer. J. Med., 55, 783PubMedCrossRefGoogle Scholar
  41. 41.
    Thompson, R. A., Carter, R., Stokes, R. P., Geddes, A. M. and Goodall, J. A. D. (1973). Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin. Exp. Immunol., 14, 335PubMedGoogle Scholar
  42. 42.
    Potter, B. J., Trueman, A. M. and Jones, E. A. (1973). Serum complement in chronic liver disease. Gut, 14, 451PubMedCrossRefGoogle Scholar
  43. 43.
    Triger, D. R., Kurtz, J. B. and Wright, R. (1974). Viral antibodies and autoantibodies in chronic liver disease. Gut, 15, 94PubMedCrossRefGoogle Scholar
  44. 44.
    Roux, M. E. B., Florin-Christensen, A., Arana, R. M. and Doniach, D. (1974). Paraproteins with antibody activity in acute viral heptatitis and chronic autoimmune liver diseases. Gut, 15, 396PubMedCrossRefGoogle Scholar
  45. 45.
    Jori, G. P. and Buonanno, G. (1972). Chronic hepatitis and cirrhosis of the liver in cryoglobulinaemia. Gut, 13, 610PubMedCrossRefGoogle Scholar
  46. 46.
    Klatskin, G. and Kantor, F. S. (1972). Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann. Intern. Med., 77, 533PubMedGoogle Scholar
  47. 47.
    Ruckstuhl, P., Cueni, B. and Schmid, M. (1971). Chronisch aggressive Hepatitis in Kombination mit chronisch destruierender nicht eitriger Cholangiitis (sog. primä r-biliä re Zirrhose). Schweiz. Med. Wschr., 101, 741PubMedGoogle Scholar
  48. 48.
    Christoffersen, P., Poulsen, H. and Scheuer, P. J. (1972). Abnormal bile duct epithelium in chronic aggressive hepatitis and primary biliary cirrhosis. Hum. Pathol., 3, 227PubMedCrossRefGoogle Scholar
  49. 49.
    Lüders, C. J., Kruck, P., Henning, H. and Look, D. (1974). Histologische und klinische Untersuchungen zur Differentialdiagnose der aggressiven chronischen Hepatitis und der primä ren biliä ren Leberzirrhose. Z. Gastroenterologie, 12, 467Google Scholar
  50. 50.
    Doniach, D. and Walker, J. G. (1969). A unified concept of autoimmune hepatitis. Lancet, i, 813CrossRefGoogle Scholar
  51. 51.
    Doniach, D. (1972). Autoimmunity in liver diseases. In Progress in Clinical Immunology. R. S. Schwartz (ed.). p. 45. Vol. 1 (New York: Grune and Stratton)Google Scholar
  52. 52.
    Klatskin, G. (1974). Drug-induced hepatic injury. In The Liver and its diseases. F. Schaffner, S. Sherlock and C. M. Leevy (eds.) p. 163 (New York: Intercontinental Medical Book Corporation)Google Scholar
  53. 53.
    Doniach, D. (1974). Autoimmunity in liver diseases in relation to genes, drugs and viruses. In Progress in Immunology. L. Brent and J. Hol-borow (eds.). Vol. 4, p. 231 (North Holland Publishing Company)Google Scholar
  54. 54.
    Martini, G. A. and Dölle, W. (1960). Idiopathische Leberzirrhose bei Frauen in der Menopause. Klin. Wschr., 38, 13PubMedCrossRefGoogle Scholar
  55. 55.
    Cook, G. C., Mulligan, R. and Sherlock, S. (1971). Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quart. J. Med., 40, 159PubMedGoogle Scholar
  56. 56.
    Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Gitnick, G. L., Elveback, L. R. and Schoenfield, L. J. (1972). Clinical biochemical and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. Gastroenterology, 63, 820PubMedGoogle Scholar
  57. 57.
    Murray-Lyon, I. M., Stern, R. B. and Williams, R. (1973). Controlled trial of prednisone and azathioprine in active chronic hepatitis. Lancet, i, 735CrossRefGoogle Scholar
  58. 58.
    Copenhagen Study Group (1974). Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of Prednisone. New Engl. J. Med., 291, 271CrossRefGoogle Scholar
  59. 59.
    Summerskill, W. H. J., Ammon, H. V. and Baggenstoss, A. H.(1974). Treatment of chronic hepatitis. In The Liver and its diseases. F. Schaffner, S. Sherlock and C. M. Leevy (eds.) p. 216 (New York: Intercontinental Medical Book Corporation)Google Scholar
  60. 60.
    Addison, T. and Gull, W. (1851). On a certain affection of the skin vitiligoidea—δ-plana, β-Tuberosa. Guy’s Hosp. Rep., 7, 265Google Scholar
  61. 61.
    Dauphinee, J. A. and Sinclair, J. C. (1949). Primary biliary cirrhosis. Canad. Med. Ass. J., 61, 1PubMedGoogle Scholar
  62. 62.
    Hanot, V. (1976). Etude sur une forme de cirrhose hypertrophique du foie (cirrhose hypertrophique avec ictère chronique) (Paris: Baillière)Google Scholar
  63. 63.
    Klemperer, P. (1937). Chronic intrahepatic obliterating cholangitis. J. Mt. Sinai Hosp., 4, 279Google Scholar
  64. 64.
    Karsner, H. T. (1943). Morphology and pathogenesis of hepatic cirrhosis. Am. J. Clin. Pathol. 13, 569Google Scholar
  65. 65.
    Rossie, R. (1930). Henke u Lubarsch, Handbuch de Speziellen Pathologischen Anatomie und Histologie, Vol. V, pt. I, BerlinGoogle Scholar
  66. 66.
    Watson, C. J. and Hoffbauer, F. W. (1946). Problem of prolonged hepatitis with particular reference to cholangiolitic type and to development of cholangiolitic cirrhosis of the liver. Ann Intern. Med., 25, 195PubMedGoogle Scholar
  67. 67.
    Thannhauser, S. J. (1950). Lipidoses, Diseases of the Cellular Lipid Metabolism, 2nd ed. (New York: Grune and Stratton)Google Scholar
  68. 68.
    Thannhauser, S. J. and Magendantz, H. (1938). The different clinical groups of xanthomatous diseases: a clinical physiological study of 22 cases. Ann. Intern. Med., 11, 1662Google Scholar
  69. 69.
    MacMahon, H. E. and Thannhauser, S. J. (1949). Xanthomatous biliary cirrhosis (clinical syndrome). Ann Intern. Med., 30, 121PubMedGoogle Scholar
  70. 70.
    Rubin, E., Schaffner, F. and Popper, H. (1965). Primary biliary cirrhosis. Am. J. Pathol, 46, 387PubMedGoogle Scholar
  71. 71.
    Ahrens, E. H. Jr., Payne, M. A., Kunkel, H. G., Eisenmenger, W. J. and Blondheim S. H. (1950). Primary biliary cirrhosis. Medicine (Baltimore), 29, 299Google Scholar
  72. 72.
    Walker, J. G., Doniach, D., Roitt, I. M. and Sherlock, S. (1965). Serological tests in diagnosis of primary biliary cirrhosis. Lancet, i, 827CrossRefGoogle Scholar
  73. 73.
    MacSween, R. N. M., Ross, Sheila K, Williamson, J. and Watkinson, G. (1975)-Primary biliary cirrohsis, Clinical and immunological associations. (In preparation)Google Scholar
  74. 74.
    Turnberg, L. A., Mahoney, M. P., Gleeson, M. H., Freeman, C. P. and Gowenlock, A. H. (1972). Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis. Gut, 13, 976PubMedCrossRefGoogle Scholar
  75. 75.
    Sherlock, S. (1974). The presentation and diagnosis of 100 patients with primary biliary cirrhosis. In The Liver and its Diseases, F. Schaffner, S. Sherlock and C. M. Leevy (eds.) p. 227. (New York: Intercontinental Medical Book Corporation)Google Scholar
  76. 76.
    Kew, M. C., Varma, R. R., Santos, H. D., Scheuer, P. J. and Sherlock, S. (1971). Portal hypertension in primary biliary cirrhosis. Gut, 12, 496PubMedCrossRefGoogle Scholar
  77. 77.
    Foulk, W. T., Baggenstoss, A. H. and Butt, H. R. (1964). Primary biliary cirrhosis: re-evaluation by clinical and histologic study of 49 cases. Gastroenterology, 47, 354PubMedGoogle Scholar
  78. 78.
    Hoffbauer, F. W. (i960). Primary biliary cirrhosis. Observations on the natural course of the disease in 25 women. Am. J. Dig. Dis., 5, 348CrossRefGoogle Scholar
  79. 79.
    Sherlock, S. (1959). Primary biliary cirrhosis (chronic intrahepatic obstructive jaundice). Gastroenterology, 37, 574PubMedGoogle Scholar
  80. 80.
    Schaffner, F. (1969). Serum cholesterol in primary biliary cirrhosis. Gastroenterology, 56, 1111PubMedGoogle Scholar
  81. 81.
    Williams, G. E. (1965). Pericholangiolitic biliary cirrhosis. J. Pathol. Bad., 89, 23CrossRefGoogle Scholar
  82. 82.
    Goudie, R. B., MacSween, R. N. M. and Goldberg, D. M. (1966). Serological and histological diagnosis of primary biliary cirrhosis. J. Clin. Pathol., 19, 527PubMedCrossRefGoogle Scholar
  83. 83.
    Scheuer, P. J. (1967). Primary biliary cirrhosis. Proc. Roy. Soc. Med., 60, 1257PubMedGoogle Scholar
  84. 84.
    MacSween, R. N. M. (1973). Mallory’s (‘alcoholic’) hyaline in primary biliary cirrhosis. J. Clin. Path., 26, 340PubMedCrossRefGoogle Scholar
  85. 85.
    Doniach, D. and Walker, J. G. (1972). Immunopathology of liver disease. In Progress in Liver Diseases. H. Popper and F. Schaffner (eds.) vol. IV, p. 381 (New York and London: Grime and Stratton).Google Scholar
  86. 86.
    Kantor, F. S. and Klatskin, G. (1967). Serological diagnosis of primary biliary cirrhosis: a potential clue to pathogenesis. Trans. Ass. Am. Physicians, 80, 267Google Scholar
  87. 87.
    Berg, P. A., Muscatello, U., Home, R. W., Roitt, I. M. and Doniach, D. (1969). Mitochondrial antibodies in primary biliary cirrhosis. II. The complement fixing antigen as a component of mitochondrial inner membranes. Br. J. Exp. Pathol. 50, 200PubMedGoogle Scholar
  88. 88.
    Ben-Yoseph, Y., Shapira, E. and Doniach, D. (1974). Further purification of the mitochondrial inner membrane autoantigen reacting with primary biliary cirrhosis sera. Immunology, 26, 311PubMedGoogle Scholar
  89. 89.
    Lam, K. C., Mistilis, S. P. and Perrott, N. (1973). Positive tissue antibody tests in patients with prolonged extrahepatic biliary obstruction. New Engl. J. Med., 286, 1400CrossRefGoogle Scholar
  90. 90.
    Doniach, D., Walker, J. G., Roitt, I. M. and Berg, P. A. (1970). ‘Autoallergic’ hepatitis. New Engl. J. Med., 282, 86PubMedCrossRefGoogle Scholar
  91. 91.
    Doniach, D. and Walker, G. (1974). Progress report. Mitochondrial antibodies (AMA). Gut, 15, 664PubMedCrossRefGoogle Scholar
  92. 92.
    Johnson, G. D., Holborow, E. J. and Glynn, L. E. (1965). Antibody to smooth muscle in patients with liver disease. Lancet, ii, 878CrossRefGoogle Scholar
  93. 93.
    MacSween, R. N. M., Armstrong, E. M., Gray, K. G. and Mason, M. (1973). Bile canalicular antibody in primary biliary cirrhosis and in other liver diseases. Lancet, i, 1419CrossRefGoogle Scholar
  94. 94.
    Fulthorpe, A. J., Roitt, I. M., Doniach, D. and Couchman, K. (1961). A stable sheep cell preparation for detecting thyroglobulin autoantibodies and its clinical application. J. Clin. Pathol., 14, 654PubMedCrossRefGoogle Scholar
  95. 95.
    MacSween, R. N. M., Hughes, Hazel, Breen, Catriona, Kitchen, P. Cathcart, Brenda and Buchanan, W. W. (1974). A comparative study of some commercially available tests for rheumatoid factor. J. Clin. Pathol., 27, 368PubMedCrossRefGoogle Scholar
  96. 96.
    Hadziyannis, S., Scheuer, P. J., Feizi, T., Naccarato, R., Doniach, D. and Sherlock, S. (1970). Immunological and histological studies in primary biliary cirrhosis. J. Clin. Pathol., 23, 95PubMedCrossRefGoogle Scholar
  97. 97.
    Diederichsen, H. (1975). Bile canalicular antibodies in non-hepatic diseases. Lancet, i, 1142CrossRefGoogle Scholar
  98. 98.
    Paronetto, F., Schaffner, F. and Popper. H. (1964). Immunocytochemi-cal and serologic observations in primary biliary cirrhosis. New Engl. J. Med., 271, 1122CrossRefGoogle Scholar
  99. 99.
    Feizi, T. (1968). Immunoglobulins in chronic liver disease. Gut, 9, 193PubMedCrossRefGoogle Scholar
  100. 100.
    Hobbs, J. R. (1967). Serum proteins in liver disease. Proc. Roy. Soc. Med., 60, 1250PubMedGoogle Scholar
  101. 101.
    MacSween, R. N. M., Home, C. H. W., Moffat, A. J. and Hughes, H. M. (1972). Serum protein levels in primary biliary cirrhosis. J. Clin. Pathol., 25, 789PubMedCrossRefGoogle Scholar
  102. 102.
    Fox, R. A., Dudley, F. J. and Sherlock, S. (1971). The serum concentration of the third component of complement βlc/βla in liver disease. Gut, 12, 574PubMedCrossRefGoogle Scholar
  103. 103.
    Potter, B. J., Elias, E. and Jones, E. A. (1974). Hypercatabolism of the third component of complement in primary biliary cirrhosis. Digestion, 10, 303 (Abstract).Google Scholar
  104. 104.
    Fox, R. A., James, D. G., Scheuer, P. J., Sharma, O. and Sherlock, S. (1969). Impaired delayed hypersensitivity in primary biliary cirrhosis. Lancet, i, 959CrossRefGoogle Scholar
  105. 105.
    MacSween, R. N. M., Galbraith, I., Thomas, M. A., Watkinson, G. and Ludlam, G. B. (1973). Phytohaemagglutinin (PHA) induced lymphocyte transformation and Toxoplasma gondii antibody studies in primary biliary cirrhosis. Clin. Exp. Immunol., 15, 35PubMedGoogle Scholar
  106. 106.
    MacSween R. N. M. and Thomas, M. A. (1973). Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors. Clin. Exp. Immunol., 15, 523PubMedGoogle Scholar
  107. 107.
    Colombo, M., Vernace, S. J. and Paronetto, F. (1974). T and B lymphocytes in primary biliary cirrhosis. Gastroenterology, 67, 783. (Abstract)Google Scholar
  108. 108.
    Sherlock, S. and Scheuer, P. J. (1973). The presentation and diagnosis of 100 patients with primary biliary cirrhosis. New Engl. J. Med., 289, 674PubMedCrossRefGoogle Scholar
  109. 109.
    Golding, P. L., Bown, R., Mason, A. M. S. and Taylor, E. (1970). ’sicca Complex’ in liver disease. Brit. Med., J., 4, 340CrossRefGoogle Scholar
  110. 110.
    Whaley, K., Webb. J., McAvoy, B. A., Hughes, G. R. V., Lee, P., MacSween, R. N. M. and Buchanan, W. W. (1973). Sjøgren’s syndrome 2. Clinical associations and immunological phenomena. Quart., J. Med., 42, 513Google Scholar
  111. 111.
    Schaffner, F. (1975). Primary biliary cirrhosis. Clinics Gastroenterol., 4, 351Google Scholar
  112. 112.
    Reynolds, T. B., Denison, E. D., Frankl, H. D., Lieberman, F. L. and Peters, R. L. (1970). New syndrome: combination of primary biliary cirrhosis, scleroderma and hereditary haemorrhagic telangiectasia. Gastroenterology, 58, 290 (Abstract).Google Scholar
  113. 113.
    Reynolds, T. B., Denison, E. K., Frankl, H. D., Lieberman, F. L. and Peters, R. L. (1971). Primary biliary cirrhosis with scleroderma, Raynaud’s phenomenon and telangiectasia. Amer. J. Med., 50, 302PubMedCrossRefGoogle Scholar
  114. 114.
    Diaz, P. A. and Schuman, B. M. (1973). Primary biliary cirrhosis with systemic sclerosis associated with Raynaud’s phenomenon and telangi-ectasiae. Gastroenterology, 64, 180 (Abstract).Google Scholar
  115. 115.
    Murray-Lyon, I. M., Thompson, R. P. H., Ansell, I. D. and Williams, R. (1970). Scleroderma and primary biliary cirrhosis. Brit. Med. J., 3, 258PubMedCrossRefGoogle Scholar
  116. 116.
    Bartholomew, L. G., Cain, J. C., Winkelmann, R. K. and Baggenstoss, A. H. (1964). Chronic disease of the liver associated with systemic scleroderma. Am. J. Dig. Dis., 9, 43PubMedCrossRefGoogle Scholar
  117. 117.
    Levrat, M., Descos, L., Trepo, C., Vandanput, F., Lesbros, F., Moulin, G. and Berthelemy, C. (1973). Association of scleroderma, Sjøgren’s syndrome and primary biliary cirrhosis. Arch. Franc. Mal. App. Dig., 62, 495Google Scholar
  118. 118.
    Turner-Warwick, M. (1968). Fibrosing alveolitis and chronic liver disease. Quart. J. Med., 37, 133PubMedGoogle Scholar
  119. 119.
    Ross, A., Heathcote, J. and Sherlock, S. (1974). A trial of azathioprine in primary biliary cirrhosis. Gastroenterology, 67, 824 (Abstract)Google Scholar
  120. 120.
    Kehayoglou, A. K., Holdsworth, C. D., Agnew, J. E., Whelton, M. J. and Sherlock, S. (1968). Bone disease and calcium absorption in primary biliary cirrhosis. Lancet, i, 715CrossRefGoogle Scholar
  121. 121.
    Ajdukiewicz, A. B., Agnew, J. E., Byers, P. D., Wills, M. R. and Sherlock, S. (1974). The relief of bone pain in primary biliary cirrhosis with calcium infusions. Gut, 15, 788PubMedCrossRefGoogle Scholar
  122. 122.
    Bulkley, B. H., Heizer, W. E., Goldfinger, S. E., Isselbacher, K. J. and Shulman, N. R. (1970). Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet, ii. 1323Google Scholar
  123. 123.
    Mathews, J. D. and Mackay, I. R. (1970). Australia Antigen in chronic hepatitis in Australia. Br. Med., J., 1, 259CrossRefGoogle Scholar
  124. 124.
    Vischer, T. L. (1970). Australia antigen and autoantibodies in chronic hepatitis. Br. Med., J., 2, 695CrossRefGoogle Scholar
  125. 125.
    Berg, P. A. (1972). Hepatitis assoziiertes Antigen (HAA). Klinische und immunologische Bedeutung. Klin. Wschr., 50, 125PubMedCrossRefGoogle Scholar
  126. 126.
    Dudley, F. J., O’Shea, M. J. and Ajdukiewicz, A. (1973). Serum autoantibodies and immunoglobulins in hepatitis associated antigen (HAA)-positive and-negative liver disease. Gut, 14, 360PubMedCrossRefGoogle Scholar
  127. 127.
    Galbraith, R. M., Eddleston, A. L. W. F., Smith, M. G. M., Williams, R., MacSween, R. N. M., Watkinson, G., Dick, H., Kennedy, L. A. and Batchelor, J. R. (1974). Histocompatibility antigens in active chronic hepatitis and primary biliary cirrhosis. Brit. Med. J., 3, 604PubMedCrossRefGoogle Scholar
  128. 128.
    MacSween, R. N. M., Laiwah, A. A. C. Y., Busuttil, A. A., Thomas, M. A., Ross, S. K., Watkinson, G., Millman, I. and Blumberg, B. S. (1973). Australia antigen and primary biliary cirrhosis. J. Clin. Pathol. 26, 335PubMedCrossRefGoogle Scholar
  129. 129.
    Reed, W. D., Eddleston, A. L. W. F., Stern, R. B. and Williams, R. (1973). Detection of Hepatitis-B antigen by radioimmunoassay in chronic liver disease and hepatocellular carcinoma in Great Britain. Lancet, ii, 690.CrossRefGoogle Scholar
  130. 130.
    Hadziyannis, S. J., Merikas, G., Moussouros, A. and Afroudakis, A. (1971). Hepatitis-associated antigen and tissue antibodies in active chronic hepatitis. Digestion, 4, 149Google Scholar
  131. 131.
    Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H. and Schoen-field, L. J. (1972). Lupoid Hepatitis, a nonentity in the spectrum of chronic active liver disease. Gastroenterology, 63, 458PubMedGoogle Scholar
  132. 132.
    Eddieston, A. L. W. F. and Williams, R. (1974). Inadequate antibody response to HB Ag or suppressor T-cell defect in development of active chronic hepatitis. Lancet, ii, 1543CrossRefGoogle Scholar
  133. 133.
    Summerskill, W. H. J. (1974). Chronic active liver disease reexamined: prognosis hopeful. Gastroenterology, 66, 450PubMedGoogle Scholar
  134. 134.
    Van Waes, L., Segers, J., Van Egmond, J., Van Nimmen, L., Barbier, F., Wieme, R. Demeulenaere, L. (1974). Chronic liver disease and hepatitis-B antigen: a prospective study. Brit. Med. J., 3, 444PubMedCrossRefGoogle Scholar
  135. 135.
    Lee, W. M., Reed, W. D., Mitchell, C. G., Galbraith, R. M., Eddleston, A. L. W., Zuckerman, A. J. and Williams, R. (1975)-Cellular and humoral immunity to hepatitis-B surface antigen in active chronic hepatitis. Brit. Med., J., 1, 705CrossRefGoogle Scholar
  136. 136.
    Hopf, U., Meyer zum Büschenfelde, K. H. and Freudenberg, J. (1974). Liver specific antigens of different species. 11. Localisation of a membrane antigen at cell surface of isolated hepatocytes. Clin. Exp. Immunol., 16, 117Google Scholar
  137. 137.
    Hopf, U., Meyer zum Büschenfelde, K. H. and Arnold, W. (1975). Cytophilic autoantibody in chronic active hepatitis. Lancet, i, 690CrossRefGoogle Scholar
  138. 138.
    Dudley, F. J., Fox, R. A. and Sherlock, S. (1972). Cellular immunity and hepatitis-associated Australia antigen liver disease. Lancet, i, 723CrossRefGoogle Scholar
  139. 139.
    Sharp, G. C., Irvin, W. S., LaRoque, R. L., Vêlez, C., Daly, V., Kaiser, A. D. and Holman, H. R. (1971). Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J. Clin. Invest., 50, 350PubMedCrossRefGoogle Scholar
  140. 140.
    Fagraeus, A., Lidman, K. and Biberfeld, G. (1974)-Reaction of human smooth muscle antibodies with human blood lymphocytes and lymphoid cell lines. Nature, 252, 246PubMedCrossRefGoogle Scholar

Copyright information

© MTP Press Ltd. 1976

Authors and Affiliations

  • R. N. M. MacSween
  • P. A. Berg

There are no affiliations available

Personalised recommendations